PubRank

George Stavrakis

Author PubWeight™ 18.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci U S A 2005 1.82
2 Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 2003 1.69
3 CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes. Circ Res 2007 1.46
4 Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart. Circulation 2007 1.37
5 IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J Clin Invest 2003 1.31
6 Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest 2005 1.29
7 Statin-induced Krüppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses. J Clin Invest 2010 1.23
8 Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury. Circulation 2009 1.15
9 C1q governs deposition of circulating immune complexes and leukocyte Fcgamma receptors mediate subsequent neutrophil recruitment. J Exp Med 2004 1.14
10 Gene expression changes evoked in a venous segment exposed to arterial flow. J Vasc Surg 2006 1.02
11 Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. Arterioscler Thromb Vasc Biol 2011 1.02
12 Neutrophils sustain pathogenic CD8+ T cell responses in the heart. Am J Pathol 2003 0.98
13 Early adaptive responses of the vascular wall during venous arterialization in mice. Am J Pathol 2004 0.98
14 Human lupus serum induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency. J Immunol 2012 0.98
15 Endothelial TNF receptor 2 induces IRF1 transcription factor-dependent interferon-β autocrine signaling to promote monocyte recruitment. Immunity 2013 0.93
16 The development of methodology for clinical measurement of 5-lipoxygenase pathway intermediates from human peripheral blood mononuclear cells. J Pharm Biomed Anal 2008 0.75